BioGaia AB (publ) (OTCMKTS:BIOGY – Get Free Report) was the recipient of a significant increase in short interest in August. As of August 14th, there was short interest totaling 131 shares, an increase of 367.9% from the July 30th total of 28 shares. Based on an average daily trading volume, of 52 shares, the days-to-cover ratio is presently 2.5 days.
BioGaia AB (publ) Stock Performance
BioGaia AB (publ) stock opened at $12.45 on Wednesday. BioGaia AB has a 12-month low of $9.64 and a 12-month high of $12.45. The company has a 50-day moving average price of $11.52 and a 200 day moving average price of $11.18.
BioGaia AB (publ) Company Profile
BioGaia AB (publ) is a Sweden-based biotechnology company specializing in the development, manufacturing and marketing of probiotic products for human and animal health. The company’s core research centers on select Lactobacillus reuteri strains, supported by extensive clinical studies to promote digestive wellness, immune support and oral health. BioGaia collaborates with academic institutions and healthcare organizations to translate scientific findings into consumer and medical applications.
BioGaia’s product portfolio includes probiotic drops, chewable tablets and oral health lozenges designed for infants, children and adults.
Featured Stories
- Five stocks we like better than BioGaia AB (publ)
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Receive News & Ratings for BioGaia AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioGaia AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
